Products
2660 products
Code | Description | Unit |
---|---|---|
EPY0000264 | Diclazuril for veterinary use - Reference Spectrum | EP unit |
EPY0000265 | Flunarizine dihydrochloride - Reference Spectrum | EP unit |
EPY0000266 | Flunarizine dihydrochloride for system suitability | EP unit |
EPY0000268 | Sodium propionate - Reference Spectrum | EP unit |
EPY0000269 | Clazuril for system suitability | EP unit |
EPY0000271 | Oxaliplatin | EP unit |
EPY0000272 | Oxaliplatin impurity B - (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']platinum (diaquodiaminocyclohexaneplatinum) | EP unit |
EPY0000273 | Oxaliplatin impurity C - (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- kO¹,kO²]dihydroxyplatinum | EP unit |
EPY0000274 | Oxaliplatin impurity D - (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethane- dioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin) | EP unit |
EPY0000275 | Dichlorodiaminocyclohexaneplatinum | EP unit |
EPY0000276 | Ipratropium impurity A - (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane | EP unit |
EPY0000277 | Colistin sulphate | EP unit |
EPY0000278 | Propanol - Reference Spectrum | EP unit |
EPY0000279 | Tri-n-butyl phosphate | EP unit |
EPY0000280 | Chondroitin sulphate sodium | EP unit |
EPY0000281 | Paroxetine hydrochloride hemihydrate | EP unit |
EPY0000282 | Tioconazole for system suitability | EP unit |
EPY0000284 | Fluticasone propionate | EP unit |
EPY0000286 | Clonazepam - Reference Spectrum | EP unit |
EPY0000288 | Piracetam | EP unit |
EPY0000289 | Polysorbate 20 - Reference Spectrum | EP unit |
EPY0000290 | Polysorbate 40 - Reference Spectrum | EP unit |
EPY0000291 | Polysorbate 60 - Reference Spectrum | EP unit |
EPY0000292 | Tioconazole - Reference Spectrum | EP unit |
EPY0000294 | Theophylline - Reference Spectrum | EP unit |
EPY0000297 | Mesalazine | EP unit |
EPY0000298 | Fluphenazine octanoate | EP unit |
EPY0000299 | Fluphenazine sulphoxide | EP unit |
EPY0000300 | Sodium aminosalicylate dihydrate - Reference Spectrum | EP unit |
EPY0000301 | Metacresol - Reference Spectrum | EP unit |
EPY0000302 | Ammonio methacrylate copolymer (type A) - Reference Spectrum | EP unit |
EPY0000303 | Ammonio methacrylate copolymer (type B) - Reference Spectrum | EP unit |
EPY0000304 | Arginine aspartate | EP unit |
EPY0000305 | Asparagine monohydrate | EP unit |
EPY0000306 | Azithromycin | EP unit |
EPY0000307 | Azithromycin impurity A - 6-demethylazithromycin | EP unit |
EPY0000309 | Bumetanide impurity A - 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid | EP unit |
EPY0000310 | Bumetanide impurity B - 3-amino-4-phenoxy-5-sulphamoylbenzoic acid | EP unit |
EPY0000311 | Celiprolol hydrochloride | EP unit |
EPY0000312 | Celiprolol impurity I - 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea | EP unit |
EPY0000313 | Clofazimine | EP unit |
EPY0000314 | Estradiol for peak identification | EP unit |
EPY0000315 | Potassium hydrogen aspartate hemihydrate | EP unit |
EPY0000316 | Mesna impurity C - 2-(Acetylsulphanyl)ethanesulphonic acid | EP unit |
EPY0000317 | Mesna impurity D - 2,2'-(disulphanediyl)bis(ethanesulphonic acid) | EP unit |
EPY0000318 | Propylene glycol dilaurate | EP unit |
EPY0000319 | Propylene glycol monolaurate | EP unit |
EPY0000320 | Clarithromycin | EP unit |
EPY0000321 | Clarithromycin for peak identification | EP unit |
EPY0000322 | Loperamide hydrochloride for system suitability | EP unit |
EPY0000323 | Methacrylic acid-ethyl acrylate copolymer (1:1) - type B | EP unit |
EPY0000324 | Esketamine hydrochloride - Reference Spectrum | EP unit |
EPY0000325 | Tilidine hydrochloride hemihydrate - Reference Spectrum | EP unit |
EPY0000326 | Azelastine hydrochloride | EP unit |
EPY0000327 | Azelastine impurity B - 1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane | EP unit |
EPY0000328 | Azelastine impurity D - 4-(4-chlorobenzyl)phthalazin-1(2H)-one | EP unit |
EPY0000329 | Azelastine impurity E - 3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one | EP unit |
EPY0000331 | Naftidrofuryl impurity F - 2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)propanoate | EP unit |
EPY0000332 | Spirapril for system suitability | EP unit |
EPY0000333 | Tiamulin hydrogen fumarate | EP unit |
EPY0000335 | Flumazenil impurity B - ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylate | EP unit |
EPY0000336 | Thiamazole | EP unit |
EPY0000337 | Mesna - Reference Spectrum | EP unit |
EPY0000338 | Esketamine impurity D - (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine) | EP unit |
EPY0000339 | Formoterol for impurity I identification | EP unit |
EPY0000340 | Formoterol fumarate for system suitability | EP unit |
EPY0000341 | Loperamide oxide monohydrate | EP unit |
EPY0000342 | Testosterone for impurity D identification | EP unit |
EPY0000343 | Testosterone for system suitability | EP unit |
EPY0000346 | Temazepam impurity F - (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione | EP unit |
EPY0000347 | Temazepam impurity G - (5RS)-7-chloro-1,4-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione | EP unit |
EPY0000348 | Insulin lispro | EP unit |
EPY0000349 | Insulin aspart | EP unit |
EPY0000350 | Oxeladin hydrogen citrate | EP unit |
EPY0000351 | Beclometasone dipropionate monohydrate | EP unit |
EPY0000352 | Beclometasone dipropionate for system suitability | EP unit |
EPY0000354 | Acarbose for identification | EP unit |
EPY0000355 | Polymyxin B sulphate for microbiological assay | EP unit |
EPY0000358 | Clofazimine for system suitability | EP unit |
EPY0000359 | Acebutolol impurity B - N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino]propoxy]phenyl]acetamide (diacetolol) | EP unit |
EPY0000361 | Ciclosporin for system suitability | EP unit |
EPY0000362 | Ciprofibrate | EP unit |
EPY0000363 | Ciprofibrate for system suitability | EP unit |
EPY0000364 | Clioquinol | EP unit |
EPY0000365 | Dodecyl gallate | EP unit |
EPY0000366 | Isradipine | EP unit |
EPY0000367 | Isradipine impurity D - methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethylpyridine-3,5-dicarboxylate | EP unit |
EPY0000368 | Octyl gallate | EP unit |
EPY0000369 | Primidone for peak identification | EP unit |
EPY0000370 | Risperidone for system suitability | EP unit |
EPY0000371 | Sestamibi labelling kit | EP unit |
EPY0000372 | Thiamazol impurity A - 2,2-dimethoxy-N-methylethanamine | EP unit |
EPY0000373 | Thiamazol impurity C - 1-methyl-2-(methylsulphanyl)-1H-imidazole | EP unit |
EPY0000374 | Colestyramine | EP unit |
EPY0000375 | Fluspirilene impurity C - 8-[4,4-bis((4-fluorophenyl)butyl]-3-(hydroxymethyl)-1- phenyl-1,3,8-triazaspiro[4.5]decan-4-one | EP unit |
EPY0000376 | Dipivefrine hydrochloride | EP unit |
EPY0000377 | Ribavirin | EP unit |
EPY0000378 | Mitomycin | EP unit |
EPY0000379 | Tiamulin - Reference Spectrum | EP unit |
EPY0000381 | Spirapril hydrochloride monohydrate | EP unit |